Profile data is unavailable for this security.
About the company
Axonics, Inc. is a medical technology company, which develops and commercializes products to treat adults with bladder and bowel dysfunction. The Company has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10cc in volume, utilizes constant current stimulation, an easy-to-use, intuitive recharge-free patient remote control and other related accessories. It engineered its recharge-free sacral neuromodulation (SNM) system to deliver constant-current stimulation. Its SNM system includes an easy-to-use wireless patient remote control that does not require recharging or replacement batteries.
- Revenue in USD (TTM)366.38m
- Net income in USD-6.09m
- Incorporated2012
- Employees797.00
- LocationAxonics Inc26 Technology DriveIRVINE 92618United StatesUSA
- Phone+1 (949) 396-6322
- Fax+1 (949) 396-6321
- Websitehttps://www.axonics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TransMedics Group Inc | 241.62m | -25.03m | 2.42bn | 584.00 | -- | 17.61 | -- | 10.01 | -0.7685 | -0.7685 | 7.43 | 4.20 | 0.4915 | 2.70 | 5.30 | 413,738.00 | -5.09 | -16.08 | -5.53 | -17.95 | 63.77 | 65.37 | -10.36 | -40.47 | 8.49 | -- | 0.7868 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Conmed Corp | 1.24bn | 64.46m | 2.46bn | 4.00k | 39.23 | 2.95 | 18.08 | 1.98 | 2.04 | 2.04 | 39.67 | 27.12 | 0.5415 | 1.75 | 5.74 | 311,185.80 | 2.80 | 0.8972 | 3.23 | 1.02 | 54.33 | 54.95 | 5.18 | 1.65 | 0.9569 | 3.03 | 0.5386 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Patterson Companies, Inc. | 6.57bn | 193.86m | 2.48bn | 7.60k | 13.63 | 2.56 | 8.85 | 0.3772 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
Procept Biorobotics Corp | 136.19m | -105.90m | 2.52bn | 626.00 | -- | 8.94 | -- | 18.49 | -2.24 | -2.24 | 2.88 | 5.53 | 0.3815 | 1.91 | 4.28 | 217,557.50 | -29.66 | -- | -33.47 | -- | 52.17 | -- | -77.75 | -- | 6.77 | -- | 0.1546 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
ICU Medical Inc | 2.26bn | -29.66m | 2.59bn | 14.00k | -- | 1.22 | 12.94 | 1.15 | -1.23 | -1.23 | 93.55 | 87.96 | 0.5080 | 2.16 | 11.79 | 161,366.10 | -0.6669 | 1.46 | -0.7491 | 1.65 | 32.75 | 34.11 | -1.31 | 2.23 | 1.06 | 0.6484 | 0.4345 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
Premier Inc | 1.32bn | 167.33m | 2.65bn | 2.80k | 15.85 | 1.11 | 9.01 | 2.01 | 1.39 | 1.39 | 10.97 | 19.95 | 0.3571 | 4.57 | 3.06 | 470,033.20 | 4.42 | 10.39 | 5.67 | 13.00 | 67.13 | 62.04 | 12.37 | 22.60 | 1.32 | 516.34 | 0.2431 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
Helen of Troy Limited | 2.00bn | 162.04m | 2.74bn | 1.90k | 17.04 | 1.73 | 13.00 | 1.37 | 6.76 | 6.76 | 83.27 | 66.81 | 0.6579 | 2.25 | 4.13 | 1,051,199.00 | 5.33 | 8.62 | 6.46 | 10.82 | 45.95 | 43.16 | 8.10 | 9.72 | 0.9755 | 4.82 | 0.3168 | -- | -6.78 | 6.98 | -35.97 | -0.488 | 66.65 | -- |
Inari Medical Inc | 493.63m | -1.64m | 2.78bn | 1.30k | -- | 5.96 | 529.30 | 5.63 | -0.0318 | -0.0318 | 8.60 | 8.05 | 0.8378 | 1.57 | 7.67 | 379,716.90 | -0.2777 | -0.5941 | -0.3129 | -0.6696 | 88.03 | 89.06 | -0.3314 | -0.6295 | 2.52 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
LivaNova PLC | 1.15bn | 17.55m | 3.02bn | 2.90k | 173.60 | 2.36 | 44.48 | 2.62 | 0.3222 | 0.3222 | 21.32 | 23.70 | 0.4883 | 2.76 | 5.79 | 397,774.10 | 0.7472 | -6.01 | 0.8627 | -7.42 | 66.86 | 66.99 | 1.53 | -13.56 | 2.51 | 1.10 | 0.3147 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Enovis Corp | 1.71bn | -54.37m | 3.41bn | 6.55k | -- | 0.9974 | 20.89 | 2.00 | -0.9987 | -0.6117 | 31.33 | 62.61 | 0.3888 | 1.59 | 6.11 | 260,640.80 | -1.23 | -0.3569 | -1.37 | -0.41 | 58.21 | 48.19 | -3.15 | -1.06 | 1.16 | 1.02 | 0.1199 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
Axonics Inc | 366.38m | -6.09m | 3.52bn | 797.00 | -- | 5.49 | 551.71 | 9.60 | -0.1285 | -0.1285 | 7.43 | 12.56 | 0.5313 | 1.35 | 7.18 | 459,697.60 | -0.8828 | -12.67 | -0.9601 | -13.76 | 74.94 | 70.04 | -1.66 | -29.68 | 8.98 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Envista Holdings Corp | 2.57bn | -100.20m | 3.67bn | 12.80k | -- | 0.8785 | 103.61 | 1.43 | -0.6022 | -0.6022 | 14.65 | 24.34 | 0.3891 | 3.99 | 6.41 | 200,507.80 | -1.52 | 1.94 | -1.79 | 2.34 | 56.52 | 57.65 | -3.90 | 5.29 | 1.90 | 5.12 | 0.2661 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Integer Holdings Corp | 1.60bn | 90.65m | 3.90bn | 10.50k | 43.49 | 2.56 | 20.57 | 2.44 | 2.68 | 2.68 | 47.30 | 45.58 | 0.5566 | 5.25 | 5.15 | 152,064.10 | 3.16 | 3.28 | 3.43 | 3.53 | 26.30 | 26.94 | 5.68 | 6.40 | 1.71 | 3.54 | 0.3898 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Lantheus Holdings Inc | 1.30bn | 326.66m | 4.27bn | 834.00 | 13.41 | 5.23 | 11.03 | 3.29 | 4.64 | 4.64 | 18.59 | 11.91 | 0.8723 | 9.46 | 5.21 | 1,554,471.00 | 21.98 | 6.69 | 25.75 | 7.73 | 63.71 | 53.90 | 25.20 | 9.02 | 5.45 | 1,235.43 | 0.4081 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Haemonetics Corporation | 1.27bn | 126.57m | 4.33bn | 3.03k | 34.54 | 4.59 | 19.70 | 3.41 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.77 | 9.97 | 7.41 | 1.76 | 25.45 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
Merit Medical Systems Inc | 1.26bn | 94.41m | 4.39bn | 6.95k | 46.82 | 3.65 | 23.80 | 3.49 | 1.62 | 1.62 | 21.55 | 20.78 | 0.6304 | 2.36 | 7.34 | 180,916.00 | 4.73 | 2.45 | 5.30 | 2.77 | 46.44 | 44.50 | 7.51 | 3.91 | 3.95 | 9.89 | 0.4064 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 5.12m | 10.08% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 4.05m | 7.97% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 3.67m | 7.24% |
Champlain Investment Partners LLCas of 31 Dec 2023 | 1.92m | 3.78% |
Bellevue Asset Management AGas of 31 Dec 2023 | 1.83m | 3.61% |
BAMCO, Inc.as of 31 Dec 2023 | 1.80m | 3.54% |
Invesco Advisers, Inc.as of 31 Dec 2023 | 1.80m | 3.54% |
AXA Investment Managers UK Ltd.as of 31 Dec 2023 | 1.56m | 3.08% |
FIAM LLCas of 31 Dec 2023 | 1.36m | 2.69% |
Loomis, Sayles & Co. LPas of 31 Dec 2023 | 1.30m | 2.56% |